Our Services
What to expect
Tell us about your concerns and previous treatments.
We review your symptoms, diagnosis and treatment history.
We discuss options suited to your clinical needs.
TMS or ketamine may be recommended when appropriate.
We monitor response, tolerability and next steps.
Treatment is recommended only when clinically appropriate following psychiatric assessment.
Psychiatrist-led care
Living with a mental health condition can feel isolating and discouraging. You are not alone. A NeuroLinks psychiatrist can review your diagnosis and treatment history and discuss appropriate options, which may include TMS or ketamine when clinically suitable.
For eligible British Columbia residents with an appropriate referral, the psychiatric assessment is covered by the Medical Services Plan (MSP).
Measurement-based care
Standardized questionnaires help evaluate symptom severity and establish a baseline before treatment. Additional measures may be selected according to individual clinical needs. Repeated assessments help monitor progress during treatment and follow-up.
Baseline
During treatment
Follow-up
Non-invasive neuromodulation
TMS therapy is typically given five days a week, over 4 to 6 weeks (accelerated TMS is available on request, which is an intensive course of treatment given over 5 days).
Rapid-acting treatment option
Ketamine therapy is typically given 2 days a week, over 3 weeks.
Some patients experience improvement within hours or days, although several treatments may be required and not everyone responds. The timing, degree and duration of benefit vary.
Ketamine is administered by a registered nurse under psychiatrist supervision, with appropriate monitoring before, during and after treatment.
Accessing treatment
Our mission is to improve the mental well-being and functioning of as many patients as possible by delivering safe and effective therapies. However, TMS and Ketamine are unfortunately not covered by the Medical Services Plan (MSP). NeuroLinks would like to increase the coverage of these therapies in the following ways:
If you have extended health insurance, you may be covered. We will issue a letter of support and can fill out necessary insurance documents to assist you with reimbursement. However, since coverage policies differ among insurance companies, please contact your agent for more information.
Veterans Affairs Canada may authorize TMS or Spravato® treatment in eligible cases. NeuroLinks also provides IM ketamine, but this treatment is not included in the current VAC benefit schedule. Coverage is not automatic, and treatment begins only after written authorization has been confirmed through VAC and Medavie Blue Cross.
Coverage may be available in selected WorkSafeBC cases. Patients should contact their WorkSafeBC representative to confirm eligibility and authorization requirements.
We can also provide information about financial institutions to help patients not delay their treatment. Please contact us for more details.
Contact NeuroLinks to learn more about psychiatric assessment, TMS and ketamine treatment.